Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia

被引：0
|
作者：
Lachowiez, Curtis [1 ]
Takahashi, Koichi [2 ]
Loghavi, Sanam [3 ]
Xiao, Lianchun [4 ]
Kadia, Tapan [2 ]
Adeoti, Maria [2 ]
Short, Nicholas [2 ]
Sasaki, Koji [2 ]
Wang, Sa [3 ]
Borthakur, Gautam [2 ]
Issa, Ghayas [2 ]
Maiti, Abhishek [2 ]
Alvarado, Yesid [2 ]
Pemmaraju, Naveen [2 ]
Bravo, Guillermo Montalban [2 ]
Masarova, Lucia [2 ]
Yilmaz, Musa [2 ]
Jain, Nitin [2 ]
Andreeff, Michael [2 ]
Jabbour, Elias [2 ]
Garcia-Manero, Guillermo [2 ]
Kornblau, Steven [2 ]
Ravandi, Farhad [2 ]
Konopleva, Marina [2 ]
Kantarjian, Hagop [2 ]
DiNardo, Courtney [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
induction chemotherapy; venetoclax; targeted therapy; acute myeloid leukemia;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-204
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [41] Single-institution experience of venetoclax combined with azacitidine in newly diagnosed acute myeloid leukemia patients
    Yu, Hong
    Wang, Chaomeng
    Lei, Yingying
    Li, Lijuan
    Wang, Huaquan
    Wang, Guojin
    Xing, Limin
    Guan, Jing
    Song, Jia
    Wu, Yuhong
    Liu, Hong
    Qu, Wen
    Wang, Xiaoming
    Shao, Zonghong
    Fu, Rong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 127
  • [42] Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation
    Zucenka, Andrius
    Vaitekenaite, Vilmante
    Maneikis, Kazimieras
    Davainis, Linas
    Pileckyte, Regina
    Trociukas, Igoris
    Peceliunas, Valdas
    Zvirblis, Tadas
    Staras, Vytautas
    Griskevicius, Laimonas
    BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2804 - 2812
  • [43] Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation
    Andrius Zucenka
    Vilmante Vaitekenaite
    Kazimieras Maneikis
    Linas Davainis
    Regina Pileckyte
    Igoris Trociukas
    Valdas Peceliunas
    Tadas Zvirblis
    Vytautas Staras
    Laimonas Griskevicius
    Bone Marrow Transplantation, 2021, 56 : 2804 - 2812
  • [44] For Patients with Adverse-Risk Acute Myeloid Leukemia, Frontline FLAG Ida with Venetoclax Is Safe and Efficacious
    Krayem, Baher
    Frisch, Avraham
    Zuckerman, Tsila
    Henig, Israel
    Yehudai-Ofir, Dana
    Nachmias, Boaz
    Khatib, Hazim
    Haran, Arnon
    Aumann, Shlomzion
    BLOOD, 2024, 144 : 4269 - 4270
  • [45] Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia
    Tessier, Steven
    Mccullough, Kristen B.
    Gangat, Naseema
    Begna, Kebede H.
    Saliba, Antoine N.
    Mangoankar, Abhishek A.
    Shah, Mithun V.
    Hogan, William J.
    Patnaik, Mrinal M.
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    LEUKEMIA & LYMPHOMA, 2025,
  • [46] Comparison of Hidac Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Study
    Tang, Man Wai
    van der Tuin, Deborah
    Aydin, Mesire
    Heijmans, Jarom
    van de Loosdrecht, Arjan A.
    Meijer, Ellen
    Rutten, Caroline E.
    Wondergem, Marielle
    Janssen, Jeroen J. W. M.
    Donker, Marjolein
    Hazenberg, Mette D.
    Zweegman, Sonja
    Biemond, Bart J.
    de Leeuw, David C.
    Nur, Erfan
    BLOOD, 2022, 140 : 3287 - 3289
  • [47] Lipemia retinalis following FLAG-Ida protocol in an 11-year-old patient with acute myeloid leukemia
    Koruk, Reyhan Hazal Kaplan
    Kocabora, Mehmet Selim
    Erdur, Sevil Karaman
    Yaman, Yontem
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2025, 35 (01) : NP5 - NP9
  • [48] Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation
    Milojkovic, Dragana
    Ibrahim, Amr
    Reid, Alistair
    Foroni, Letizia
    Apperley, Jane
    Marin, David
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03): : 473 - 474
  • [49] FLAG-IDA Has Significant Activity As Frontline Induction or Salvage Therapy for Patients with High Risk and/or Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Bhella, Sita D.
    Atenafu, Eshetu G.
    Schuh, Andre C.
    Minden, Mark D.
    Schimmer, Aaron D.
    Gupta, Vikas
    Seftel, Matthew D.
    Alam, Naheed
    Lutynski, Andrzej
    Rostom, Amr
    Rydlewski, Anna
    Yee, Karen
    BLOOD, 2014, 124 (21)
  • [50] Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia
    Short, Nicholas J.
    Wierzbowska, Agnieszka
    Cluzeau, Thomas
    Laribi, Kamel
    Recher, Christian
    Czyz, Jaroslaw
    Ochrem, Bogdan
    Ades, Lionel
    Gallego-Hernanz, Maria Pilar
    Heiblig, Mael
    Audisio, Ernesta
    Zarzycka, Ewa
    Li, Shuli
    Ferenc, Nicholas
    Yeh, Tammie
    Faller, Douglas V.
    Sedarati, Farhad
    Papayannidis, Cristina
    LEUKEMIA & LYMPHOMA, 2025, 66 (03) : 458 - 468
12345